Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Capitan Silver Announces Upsize of Non-Brokered Private Placement to C$2.0 Million
-
Austral Gold Files 2023 Annual Report
-
Atlas Lithium Secures US$ 30,000,000 Strategic Investment and Offtake Agreement from Mitsui
-
Hempacco Announces It Has Regained Compliance with Nasdaq Listing Rule 5550(a)(2)
-
Ramp Metals Provides Exploration Update and Announces Drilling Campaign
-
Canadian Metals Strengthens Board of Directors with the Appointment of Quentin Yarie
-
Amex Expands Gratien Zone with the Best Intersect to Date of 76.69 g/t Au over 3.50 m
-
InterSystems and IPA’s Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with LENSai for AI-Driven Healthcare Applications
-
Clough Global Equity Fund Section 19(a) Notice
-
Clough Global Dividend and Income Fund Section 19(a) Notice
-
C3 Metals Jamaica Copper-Gold Exploration Update and Discovery Targets
-
Reaves Utility Income Fund Section 19(a) Notice
-
Allprostar to Showcase its New Camping Series at Hong Kong Global Sources Sports & Outdoor Show 2024
-
Chris Diehl Returns to 101 Mobility as Director of National Accounts
-
Gogo Testing for Global Broadband Antenna Achieves Major Milestone
-
Clough Global Opportunities Fund Section 19(a) Notice
-
New Report: Visibility Voids Are Exposed When Lacking Insight into Key Data Elements at the Item-Level as the Supply Chain Industry Progresses to End-to-End Traceability
-
Shimmick Corporation Announces Fourth Quarter and Fiscal Year 2023 Results
-
atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights
-
Aya Gold & Silver: Record 2023 Production, Revenue and Operating Cash Flow
-
Giyani Satisfies Key Condition for Drawdown Under US$16 Million IDC Facility
-
Troilus Provides Operational Update
-
Stran & Company Reports 28.7% Increase in Sales and Achieves Profitability for the 2023 Fiscal Year
-
Syndax Announces Completion of Enrollment in AUGMENT-101 Pivotal Trial Cohort of Patients with Relapsed/Refractory mNPM1 Acute Myeloid Leukemia
-
Walgreens Boots Alliance Reports Fiscal 2024 Second Quarter Results
-
Availability of 2023 Annual Report on Form 20-F for Year Ended December 31, 2023
-
OceanaGold Files Annual Information Form and Technical Reports for Haile and Macraes
-
Canadian Solar Comments on Complaint Filed by Maxeon Solar
-
Trilogy Metals Announces Date of Annual Shareholders Meeting and Provides Update on Ambler Access Road
-
Azurite Intermediate Holdings, Inc. Announces Termination of Tender Offer and Consent Solicitation and Commencement of Change of Control Offer
-
Can-Fite Reports 2023 Financial Results and Clinical Update
-
Mannatech Reports Financial Results for Fourth Quarter and Full Year 2023
-
Better Home & Finance Holding Company Announces Fourth Quarter and Full Year 2023 Results
-
Alight’s Latest Release of Alight Worklife® to Unlock Value for Organizations and Their People
-
NMG Provides Commercial and Operational Update upon Filing 2023 Financial Reports: Significant Progress over the Year in Advancing North America’s Mine-to-Battery-Material Graphite Production
-
D-Wave Reports Fourth Quarter and Year-End 2023 Results
-
GenFleet and BeiGene Enter into Trial Collaboration for a Potentially First-in-class Combination Therapy to Initiate Phase Ib/II Study of GFH009 (CDK9 inhibitor) and BRUKINSA® (zanubrutinib) Treating
-
Bedford Media To Relaunch LIFE Magazine
-
Garzone Construction Streamlines New Construction and Builds Dream Homes in Parkland and Pompano Beach
-
CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates
-
BCE Q1 2024 results to be announced May 2
-
Setting the Standard: Opus IVS Delivers Unprecedented Diagnostic Support with Giotto Release 22.1
-
Nested Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for NST-628, a Novel Pan-RAF/MEK Molecular Glue
-
Milestone Pharmaceuticals Announces Resubmission of New Drug Application for Etripamil for Treatment in Paroxysmal Supraventricular Tachycardia
-
Delta Development Team Receives SBIR Phase Two Enhancement for Innovations in Battlefield Blood Storage
-
CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 BUSINESS AND FINANCIAL RESULTS
-
Kelonia Therapeutics Appoints Kristen Hege, M.D., and Mathai Mammen, M.D., Ph.D., to Board of Directors
-
Harri Takes Frontline Employee Experience Platform On the Road, Set to Attend McDonald’s Worldwide Convention
-
Laser Photonics’ CleanTech Simplifies Gas Tank Cleaning in Motorcycle Repair & Restoration
-
SharkNinja Appoints Patraic Reagan as Chief Financial Officer


